| Outgoing Relation(s) |
| anti-HBV agent (CHEBI:64951) is a antiviral agent (CHEBI:22587) |
| Incoming Relation(s) |
| alismorientol A (CHEBI:65386) has role anti-HBV agent (CHEBI:64951) |
| exophillic acid (CHEBI:232062) has role anti-HBV agent (CHEBI:64951) |
| fatsicarpain A (CHEBI:69216) has role anti-HBV agent (CHEBI:64951) |
| fatsicarpain C (CHEBI:69218) has role anti-HBV agent (CHEBI:64951) |
| fatsicarpain D (CHEBI:69219) has role anti-HBV agent (CHEBI:64951) |
| fatsicarpain F (CHEBI:69221) has role anti-HBV agent (CHEBI:64951) |
| fatsicarpain G (CHEBI:69222) has role anti-HBV agent (CHEBI:64951) |
| helioxanthin (CHEBI:191856) has role anti-HBV agent (CHEBI:64951) |
| kadsuphilactone B (CHEBI:66130) has role anti-HBV agent (CHEBI:64951) |
| lamivudine (CHEBI:63577) has role anti-HBV agent (CHEBI:64951) |
| ophioglonin (CHEBI:66823) has role anti-HBV agent (CHEBI:64951) |
| pedunculosumoside A (CHEBI:67873) has role anti-HBV agent (CHEBI:64951) |
| pedunculosumoside C (CHEBI:67875) has role anti-HBV agent (CHEBI:64951) |
| robustaflavone (CHEBI:8881) has role anti-HBV agent (CHEBI:64951) |
| saikosaponin C (CHEBI:189704) has role anti-HBV agent (CHEBI:64951) |
| salutaridine (CHEBI:17225) has role anti-HBV agent (CHEBI:64951) |
| schisanwilsonene A (CHEBI:66432) has role anti-HBV agent (CHEBI:64951) |
